182 related articles for article (PubMed ID: 19652116)
1. Letter by barrios et Al regarding article, "heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial".
Barrios V; Escobar C; Echarri R
Circulation; 2009 Aug; 120(5):e31; author reply e32. PubMed ID: 19652116
[No Abstract] [Full Text] [Related]
2. Letter by Ben-Dov and Bursztyn regarding article, "Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial".
Ben-Dov IZ; Bursztyn M
Circulation; 2007 Jan; 115(2):e18; author reply e19. PubMed ID: 17228008
[No Abstract] [Full Text] [Related]
3. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI
Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474
[No Abstract] [Full Text] [Related]
4. A family physician questions the conclusions from ALLHAT.
Standridge JB
Am J Hypertens; 2004 Apr; 17(4):361-5. PubMed ID: 15062891
[TBL] [Abstract][Full Text] [Related]
5. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
Beevers DG; Lee KW; Lip GY
J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
[No Abstract] [Full Text] [Related]
6. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
[TBL] [Abstract][Full Text] [Related]
7. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
Elliott WJ
Am J Hypertens; 1996 Apr; 9(4 Pt 1):409-11. PubMed ID: 8722446
[No Abstract] [Full Text] [Related]
8. Trials and tribulations.
Packard CJ
Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357
[No Abstract] [Full Text] [Related]
9. [Uneven sex distribution in the cardiovascular trials--an exaggerated problem].
Melander H; Rastad JA
Lakartidningen; 2006 Jun 8-13; 103(23):1856-9. PubMed ID: 16838599
[No Abstract] [Full Text] [Related]
10. [After the ALLHAT trial, what do we know about treatment for hypertension that we did not know before?].
González-Juanatey JR
Rev Esp Cardiol; 2003 Jul; 56(7):642-8. PubMed ID: 12855144
[No Abstract] [Full Text] [Related]
11. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.
Hebert LA; Rovin BH; Hebert CJ
Nat Clin Pract Nephrol; 2007 Feb; 3(2):60-1. PubMed ID: 17251990
[No Abstract] [Full Text] [Related]
12. [ALLHAT's clamour, referee's and editor's compassion, and Hasan Pulur].
Timuralp B
Anadolu Kardiyol Derg; 2003 Sep; 3(3):197-8. PubMed ID: 12967882
[No Abstract] [Full Text] [Related]
13. [Statins in practice of the vascular surgeon and cardiologist].
Pokrovskiĭ AV; Suntsov DS
Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
[TBL] [Abstract][Full Text] [Related]
14. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
Onuigbo MA
Arch Intern Med; 2009 Oct; 169(19):1810; author reply 1810-1. PubMed ID: 19858442
[No Abstract] [Full Text] [Related]
15. Letter by Tartiere et al regarding article, "Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota".
Tartière JM; Tartière-Kesri L; Cohen Solal A
Circulation; 2007 Dec; 116(24):e562; author reply e563. PubMed ID: 18071083
[No Abstract] [Full Text] [Related]
16. Hypertension, heart failure, and ejection fraction.
Little WC
Circulation; 2008 Nov; 118(22):2223-4. PubMed ID: 19001020
[No Abstract] [Full Text] [Related]
17. ALLHAT: a saga of missed opportunities.
McInnes GT
J Hum Hypertens; 2003 Jun; 17(6):373-7. PubMed ID: 12764398
[No Abstract] [Full Text] [Related]
18. [Statines for all or individualized lipid lowering therapy?].
Parhofer K
MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
[No Abstract] [Full Text] [Related]
19. Does anticoagulation benefit patients with congestive heart failure (CHF) who have reduced left ventricular ejection fraction (LVEF) and are in normal sinus rhythm?
Shah N; DeLeon D; Schwiebert LP; Mold JW
J Okla State Med Assoc; 2009 Apr; 102(4):126-7. PubMed ID: 19504981
[No Abstract] [Full Text] [Related]
20. Network meta-analysis of heart failure prevention by antihypertensive drugs.
Elliott WJ; Basu S; Meyer PM
Arch Intern Med; 2011 Mar; 171(5):472; author reply 472-3. PubMed ID: 21403048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
